The poultry pharmaceuticals market deals with the production and supply of medicines and vaccines for poultry birds. The market comprises antibiotics, anti-inflammatory, antifungal, and parasiticides that are used to treat various common poultry diseases. Regular consumption of antibiotics and vaccines in poultry feed helps maintain bird health and maximize productivity. The global poultry population has been increasing steadily to meet the rising demand for chicken and eggs. However, intensive poultry farming practices have led to increased prevalence of diseases.
Poultry Pharmaceuticals Market is estimated to be valued at USD 8.7 Bn in 2025 and is expected to reach USD 15.7 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.
Key Takeaways
Key players operating in the poultry pharmaceuticals market are Bayer AG, Bimeda, Ceva Sante Animale, Elanco Animal Health (Eli Lilly and Company), Merck Animal Health, Merial Animal Health (Sanofi), Virbac, Boehringer Ingelheim, Zoetis, Inc., Pacific GeneTech, and Avivagen Inc.
The Poultry Pharmaceuticals Market Demand is growing continuously, especially in developing Asian and Latin American countries. Higher consumption of protein-rich poultry products is fueling the growth of the global poultry industry. Growing poultry production is further augmenting the demand for veterinary medicines and vaccines to prevent diseases in commercial poultry farms.
Several leading pharmaceutical companies are expanding their reach in international markets through acquisitions and collaborations. For instance, Zoetis acquired Phibro Animal Health Corporation in 2021 to strengthen its presence in poultry producing regions like Latin America and Asia Pacific.
Market Key Trends
Rising imports of poultry meat in major markets like the US, EU, and China has increased the risk of transboundary animal diseases. Stringent quarantine policies and vaccination protocols are being implemented at import borders to control the spread of exotic diseases. This is propelling the demand for immunization products in the poultry pharmaceuticals sector. Growing awareness regarding food safety, animal welfare, and AMR is also encouraging poultry farmers to closely monitor bird health through preventive medicine rather than therapeutic drugs alone.
Porter's Analysis
Threat of new entrants: Low capital requirement and expertise allows new companies to enter the market easily. However, established brands and regulatory approvals are barriers for new players.
Bargaining power of buyers: Large buyers such as integrators have significant negotiating power over manufacturers due to the consolidated nature of the industry. However, need for specialized products keeps their power in balance.
Bargaining power of suppliers: Key inputs such as Active Pharmaceutical Ingredients have few suppliers globally. This enables them to influence prices significantly. Suppliers are looking to integrate vertically to capture more profits.
Threat of new substitutes:No strong substitutes exist for pharmaceutical products in poultry farming. Preventive vaccines and antibiotics will continue to dominate the market.
Competitive rivalry: Top players compete on innovation, quality, and building consumer loyalty programs. Patent expiries increase competition between generic manufacturers.
North America accounts for the largest share in the poultry pharmaceuticals market in terms of value due to advanced poultry farming practices and strict regulatory policies. Asia Pacific is the fastest growing regional market driven by rising meat consumption, growing middle class, and government focus on commercial poultry. China dominates the APAC poultry pharmaceuticals market both in value and volume terms as the world's largest producer and consumer of poultry meat.
Get This Report in Japanese Language - 家禽医薬品市場
Get This Report in Korean Language -가금류 의약품 시장
About Author:
Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.
(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)
